BioIndustry Association

What BioIndustry Association does

The BioIndustry Association (BIA), founded in 1989 and headquartered in London, is the UK-wide trade association representing the innovative life sciences and biotech industry. It serves over 600 member companies spanning early-stage biotech, scale-ups, large pharmaceutical firms, venture capital, academic institutions, and service providers across the UK life sciences ecosystem. The association's core function is sector advocacy and ecosystem coordination: it conducts policy engagement with MHRA, NICE, the Office for Life Sciences, and parliamentarians (logging 60 influence meetings in the latest reporting period), and convenes the community through flagship events, leadership programmes, and proprietary research reports.

BIA's product portfolio is built around member services rather than technology products. Flagship offerings include London Life Sciences Week (co-convened with MedCity and London & Partners), BioSolutions UK, TechBio UK, the Milner Therapeutics Symposium (750 attendees), the annual Gala Dinner (780 guests in 2026), Parliament Day, and PULSE — a three-day leadership and entrepreneurship programme delivered at the Francis Crick Institute. Research outputs include the UK Biotech Financing Reports (quarterly), Vision 2035, Women in Biotech Leadership Reports, and Cell and Gene Therapy reports. The Business Solutions purchasing programme delivered an estimated £10M in member savings over the past 12 months. No proprietary technology platform or AI/ML product was identified in the available data.

BIA operates a membership-based non-profit revenue model combining tiered membership dues, event registration and sponsorship, and Annual Supporter contributions from major organisations including AstraZeneca, Johnson & Johnson, Cytiva, LifeArc, Cooley, HSBC Innovation Banking, and Canary Wharf Group. Specific pricing is not publicly disclosed. Governance is member-directed through an elected board of directors, with leadership transitioning in 2025 from long-tenured CEO Steve Bates OBE to incoming CEO Professor Chris Molloy alongside Managing Director Jane Wall.

Name

BioIndustry Association

Legal name

BioIndustry Association

Website

https://bioindustry.org

Company type

Private

Founded year

1989

Operating status

Operating

Headcount range

51–100 employees

Short description

The BioIndustry Association (BIA) is the UK trade association for the innovative life sciences and biotech industry, serving over 600 member companies through policy advocacy, flagship events, leadership programmes, and proprietary sector research.

Ownership category

akta.pro rank

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Distribution channels3 records

Marketing channels5 records

Core offering

The BioIndustry Association (BIA) is the UK trade association for innovative life sciences and biotech companies, serving over 600 member firms. It sells membership subscriptions, sponsorships, event registrations, and access to leadership development programmes, industry reports, and policy advocacy services. Revenue is generated through tiered membership fees, event ticketing, annual supporter programmes with major pharma and service partners, and group-purchasing discounts via the Business Solutions programme.

Product overview

The BioIndustry Association (BIA) is a trade association for the UK life sciences and biotech industry, offering a portfolio of event-based programmes, leadership development initiatives, research publications, and membership services. The core offering includes major conferences (BioSolutions UK, London Life Sciences Week, TechBio UK, TechBio X, Gala Dinner, Parliament Day), leadership programmes (PULSE, Expert Leader Programme, BioStart, She Steers NEDs in Biotech), and research reports (UK Biotech Financing Reports, Vision 2035, Women in Biotech Leadership Reports, Cell and Gene Therapy Reports). The association serves over 600 member companies through networking events, policy advocacy, business solutions, and informational resources including newsletters, blogs, and an innovation map directory. The BIA positions itself as the voice of innovative life sciences, connecting founders, scale-ups, and investors while shaping policy and showcasing UK biotech leadership.

Differentiator

Problem solved

Functional benefit

Products and services

• BIA Membership Tiered subscription membership for UK life sciences and biotech companies providing policy advocacy, networking with investors and partners, expert committees, business solutions savings, and exclusive event access.
• BioSolutions UK Annual industry conference focused on engineering biology and biosolutions, bringing together innovators, policymakers, and investors to discuss industrial transformation through biotechnology.
• London Life Sciences Week Annual week-long event co-convened by BIA, MedCity, and London & Partners celebrating the UK's life sciences sector with premier global gatherings, networking, and partnerships connecting 2,400 biotech companies and 1,300+ investors.
• PULSE Programme
• Expert Leader Programme
• BioStart
• Women in Biotech
• TechBio UK
• TechBio X
• TechBio Boost Programme
• Milner Pitch Day
• Milner Therapeutics Symposium
• Business Solutions Programme
• UK Biotech Financing Reports
• Vision 2035
• Innovation Map

Quantifiable outcome

• £10 million saved by BIA members through Business Solutions programme in past 12 months
• +2 more outcomes

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

19 partnerships are on record, tiered core.

• LifeArccoreOthersLifeArc is a member and Annual Supporter of BIA. As a self-funded charitable medical research organisation, LifeArc collaborates with BIA on policy advocacy and industry initiatives focused on translational science and patient outcomes.
• Johnson & Johnson InnovationcoreOthersJohnson & Johnson Innovation is an Annual Supporter of BIA and collaborates on leadership programmes including PULSE. The partnership supports entrepreneurship development in UK life sciences.
• AstraZenecacoreOthersAstraZeneca is an Annual Supporter of BIA, providing funding and strategic support for the association's activities in policy advocacy and ecosystem development.
• CytivacoreOthersCytiva is an Annual Supporter of BIA and participates in the life sciences ecosystem, supporting industry events and initiatives.
• Canary Wharf GroupcoreOthersCanary Wharf Group is an Annual Supporter and Strategic Partner for events including Women in Biotech Canary Wharf events and BioSolutions UK.
• CooleycoreOthersCooley is an Annual Supporter of BIA, providing legal industry expertise to the life sciences community.
• HSBC Innovation BankingcoreOthersHSBC Innovation Banking is an Annual Supporter and provides banking services to BIA members with preferential terms.
• MedCitycoreStrategic or Co-development PartnerMedCity co-convenes London Life Sciences Week with BIA and London & Partners, bringing together biotech leaders, innovators, and global investors for a week celebrating UK life sciences sector.
• London & PartnerscoreStrategic or Co-development PartnerLondon & Partners co-convenes London Life Sciences Week with BIA and MedCity, promoting London as a global hub for biotech innovation and investment.
• The Francis Crick InstitutecoreStrategic or Co-development PartnerThe Francis Crick Institute hosts BIA's PULSE leadership programme, providing venue and expertise for the three-day entrepreneurship and leadership development course.
• Wellcome Sanger InstitutecoreOthersWellcome Sanger Institute is an active BIA member. BIA CEO Steve Bates noted the partnership helps expand the reach and impact of Sanger's science at scale.
• Blood Cancer UKcoreOthersBlood Cancer UK was BIA's Charity Partner of 2025. The partnership aimed to address disparities in blood cancer outcomes across the UK and amplify the charity's work to improve survival rates.
• IBioIC (Industrial Biotechnology Innovation Catalyst)coreStrategic or Co-development PartnerBIA partners with IBioIC on biosolutions outreach and international trade missions, including leading UK presence at Bio Innovations Europe.
• Department for Business and Trade (DBT)coreStrategic or Co-development PartnerDBT partners with BIA on international trade missions including UK reception at JP Morgan Healthcare Conference, Swiss Biotech Day delegation, and BIO International Convention participation.
• Office for Life Sciences (OLS)coreStrategic or Co-development PartnerOLS collaborates with BIA on policy initiatives, hosting the UK reception at JP Morgan Healthcare Conference and supporting UK life sciences strategy development.
• Relation TherapeuticscoreTechnology or IntegrationBIA features Relation Therapeutics as a member redefining TechBio. The company is pioneering a 'Lab-in-the-Loop' platform combining functional cell atlases with machine learning for drug discovery.
• Isomorphic LabscoreTechnology or IntegrationBIA highlights Isomorphic Labs' $2.1 billion Series B raise as a case study of UK TechBio strength at the intersection of AI and life sciences.
• University of ManchestercoreStrategic or Co-development PartnerBIA member Poolbeg Pharma partners with University of Manchester on the RISE programme (Reducing Immune Stress from Excess cytokine release), a £3.4 million MRC Prosperity Partnership grant for cancer immunotherapy research.
• The Christie NHS Foundation TrustcoreStrategic or Co-development PartnerThe Christie partners with Poolbeg Pharma and University of Manchester on the RISE programme for cancer immunotherapy research, positioning the UK as a global leader in safe delivery of cancer immunotherapies.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• France Biotech: France Biotech is the French association of life sciences entrepreneurs and innovative biotech companies. It operates the same model as BIA: membership-based advocacy, events, and investor engagement focused on growing the national biotech ecosystem.
• Biotechnology Innovation Organization (BIO): BIO is the largest US trade association for the biotechnology industry, representing companies, academic institutions, and related organizations. It is the closest international analogue to BIA in terms of advocacy, large-scale convention (BIO International Convention), and member services — BIA explicitly participates in BIO events.
• Swiss Biotech Association: The Swiss Biotech Association is the national industry association for the Swiss biotech sector. It runs the Swiss Biotech Day, a flagship event BIA actively attends with UK delegations, and is a comparable small-organisation, national-scope trade body supporting a national biotech ecosystem.
• BIO Deutschland: BIO Deutschland is the German biotechnology industry association representing German biotech companies and their partners. Like BIA, it is a member-funded trade body focused on national-level policy advocacy, networking, and visibility for the domestic biotech sector.
• Biotechnology Innovation Organization of Canada (BIO Canada / BIOTECanada): BIOTECanada is the national trade association for Canada's biotechnology industry. It performs analogous member-services, policy advocacy, and conference functions to BIA at a national level.
• Association of the British Pharmaceutical Industry (ABPI): ABPI is the UK trade association for the branded pharmaceutical industry, headquartered in London. It overlaps with BIA on UK life-sciences policy advocacy, government engagement (including the Office for Life Sciences), and represents the broader pharma value chain of which BIA's biotech members are a part.
• AusBiotech: AusBiotech is Australia's national biotechnology industry association, with similar membership, policy advocacy, and event programming. It is the closest Asia-Pacific peer to BIA in organisational scope and serves as a model international comparator, especially given Brandon Capital's UK-Australia cross-presence referenced in BIA's partner list.
• Medicines Australia: Medicines Australia represents the innovative medicines industry in Australia and overlaps with BIA in scope (innovative therapeutics policy advocacy and member services) though it is more pharma-weighted. Comparable in operating model and mission focus.
• EuropaBio: EuropaBio is the European Association for Bioindustries, representing biotechnology and life sciences at the EU level. It is structurally comparable to BIA but operating at a supranational level, often co-advocating with national associations like BIA on cross-border regulatory and financing issues.

Emerging players

• MedCity: MedCity is a UK life sciences cluster organisation co-convening London Life Sciences Week with BIA. It has overlapping London-region focus and member overlap but is a smaller, more localised cluster-development body rather than a full national trade association.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/bioindustry-association
• Xx.com/bia_uk

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioIndustry Association